BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8393158)

  • 1. p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cells.
    Schmieg FI; Simmons DT
    Oncogene; 1993 Aug; 8(8):2043-50. PubMed ID: 8393158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts.
    Conzen SD; Cole CN
    Oncogene; 1995 Dec; 11(11):2295-302. PubMed ID: 8570180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC; Levine AJ
    Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
    Hansen RS; Braithwaite AW
    Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency.
    Tiemann F; Deppert W
    Oncogene; 1994 Jul; 9(7):1907-15. PubMed ID: 8208537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transforming oncoproteins determine the mechanism by which p53 suppresses cell transformation: pRb-mediated growth arrest or apoptosis.
    Hansen R; Reddel R; Braithwaite A
    Oncogene; 1995 Dec; 11(12):2535-45. PubMed ID: 8545110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
    Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
    Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of SV40 large T antigen induced apoptosis by small T antigen.
    Kolzau T; Hansen RS; Zahra D; Reddel RR; Braithwaite AW
    Oncogene; 1999 Sep; 18(40):5598-603. PubMed ID: 10523837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localization is essential for the activity of p53 protein.
    Shaulsky G; Goldfinger N; Tosky MS; Levine AJ; Rotter V
    Oncogene; 1991 Nov; 6(11):2055-65. PubMed ID: 1719467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E; Boldyreff B; Scheidtmann KH
    Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation of SV40 large T antigen and the cellular protein p53 in maintenance of cell transformation.
    Deppert W; Steinmayer T; Richter W
    Oncogene; 1989 Sep; 4(9):1103-10. PubMed ID: 2674854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells.
    Reihsaus E; Kohler M; Kraiss S; Oren M; Montenarh M
    Oncogene; 1990 Jan; 5(1):137-45. PubMed ID: 2157179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein.
    Dkhissi F; Raynal S; Jullien P; Lawrence DA
    Oncogene; 1999 Jan; 18(3):703-11. PubMed ID: 9989820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limits of transforming competence of SV40 nuclear and cytoplasmic large T mutants with altered Rb binding sequences.
    Tedesco D; Fischer-Fantuzzi L; Vesco C
    Oncogene; 1993 Mar; 8(3):549-57. PubMed ID: 8382355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The induction of apoptosis by SV40 T antigen correlates with c-jun overexpression.
    Chen SL; Tsao YP; Chen YL; Huang SJ; Chang JL; Wu SF
    Virology; 1998 May; 244(2):521-9. PubMed ID: 9601520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of rare p53 mutants from carcinogen-treated albumin-simian virus 40 T-antigen transgenic rats.
    Haas MJ; Pitot HC
    Mol Carcinog; 1998 Feb; 21(2):128-34. PubMed ID: 9496913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.